CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY

Clinical trials for CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY explained in plain language.

Never miss a new study

Get alerted when new CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY trials appear

Sign up with your email to follow new studies for CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug aims to calm heart arteries after attack

Disease control Not yet recruiting

This study is testing whether a new drug called ziltivekimab can help stabilize the fatty plaques in heart arteries after a heart attack. About 332 participants who recently had a heart attack will be randomly assigned to receive either the new drug or a placebo injection once a …

Matched conditions: CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY

Phase: PHASE3 • Sponsor: ECRI bv • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY

Get alerted when new CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY trials appear

New drug aims to calm heart arteries after attack